Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Boston Scientific's Business Segments

Boston Scientific's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
2
Per the company's own filing, this quarter
Largest Segment
Cardiovascular
67.3% of revenue
Total Revenue
$ 5,204
Consolidated, this quarter
Regions Reported
1
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BSX/segments
https://api.csimarket.com/api/v1/companies/BSX/geographic
https://api.csimarket.com/api/v1/companies/BSX/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

67%largest
  • Cardiovascular67.3%
  • MedSurg32.7%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
CardiovascularQ1 FY2026$ 3,50367.3%-
MedSurgQ1 FY2026$ 1,70132.7%-

Revenue Share by Region - Q1 FY2026

37%largest
  • Non-US36.9%

Revenue by Geographic Region - Q1 FY2026

RegionPeriodRevenue
(Millions)
% of Total
Non-USQ1 FY2026$ 1,92036.9%

Revenue by Product & Service Category - Q1 FY2026

12%largest
  • Electrophysiology (EP)11.6%
  • Interventional Cardiology Therapies10.6%
  • Global Urology and Pelvic Health Reporting Unit8.9%
  • Watchman8.9%
  • Global Endoscopy (Endo) Reporting Unit8.6%
  • Cardiac Rhythm Management6.7%
  • Global Neuromodulation (NM) Reporting Unit4.5%
  • Interventional Oncology and Embolization3.3%

Revenue by Product & Service Category - Q1 FY2026

CategoryPeriodRevenue
(Millions)
% of Total
Electrophysiology (EP)Q1 FY2026$ 60311.6%
Interventional Cardiology TherapiesQ1 FY2026$ 55210.6%
Global Urology and Pelvic Health Reporting UnitQ1 FY2026$ 4658.9%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

5 more categories available

Sign in to unlock the full Boston Scientific dataset.

Description of Boston Scientific

Boston Scientific Corporation operates as a leading global developer, manufacturer, and marketer of medical devices, focusing on a diverse array of interventional medical specialties. Their business segments encompass interventional cardiology, peripheral interventions, neurovascular intervention, electrophysiology, vascular surgery, endoscopy, oncology, urology, and gynecology.

Founded in 1979, Boston Scientific has been at the forefront of advancing less-invasive medicine. The company offers a comprehensive portfolio of innovative products, technologies, and services designed to enhance patient care across various specialties. Their medical devices are typically inserted through natural openings or small incisions, allowing for minimally invasive diagnostic and therapeutic procedures.

Boston Scientific is committed to improving patients quality of life by providing alternatives to traditional surgical methods, making significant contributions to the field of healthcare through its continual investments in research and development, expansion into emerging markets, and focus on advancing medical technology to meet the evolving needs of healthcare providers and patients alike.
Boston Scientific Corporation is a prominent global player in the medical device industry, dedicated to providing innovative solutions across various healthcare segments. Their extensive product offerings and services span critical medical fields, with a key emphasis on improving patient outcomes through technological advancements. Below is a detailed overview of the segments, products, and services offered by Boston Scientific, with a particular focus on the updates within their cardiovascular division.

Cardiovascular Segment

Boston Scientifics cardiovascular division is renowned for its comprehensive suite of products and services that address a wide spectrum of cardiac and vascular disorders. The segment is characterized by advancements in minimally invasive techniques, facilitating better recovery and outcomes for patients.

Coronary Stent Business

1. Drug-Eluting Stents (DES):
- PROMUS®: Featuring the drug everolimus, this stent system is designed to minimize the risk of restenosis. Since its launch in 2006, it has seen continuous enhancements and expansions into diverse markets with next-generation solutions targeting broader applications.
- TAXUS®: Another pivotal drug-eluting stent known for its polymer and drug formulation designed to combat coronary artery blockage effectively.

2. Bare-Metal Stents:
- Liberte® Stent System: Boston Scientific’s leading bare-metal stent, engineered for optimal deliverability and anatomically-driven flexibility, serving as a foundational product that supports advanced drug-eluting innovations.

Cardiac Surgery

Boston Scientific contributes a variety of crucial devices in the realm of cardiac surgery, including:
- Endoscopic Vessel Harvesting Devices: For optimal procurement of veins or arteries for bypass procedures.
- Surgical Ablation Systems: These systems are designed to assist in the treatment of atrial fibrillation.
- Minimally Invasive Coronary Artery Bypass Surgery Devices.

Coronary Revascularization

Focusing on the treatment of atherosclerosis, Boston Scientific offers a variety of devices under this category, including:
- Balloon Catheters: Devices like the Maverick® balloon and Cutting Balloon® facilitate effective angioplasty procedures.
- Rotational Atherectomy Systems: Employed in plaque removal to restore arterial patency.
- Guide Wires and Accessories: Essential for the precise placement of stents and catheters during interventions.

Intraluminal Ultrasound Imaging

- iLab® Ultrasound Imaging System: This system utilizes intraluminal ultrasound technology for enhanced assessment and real-time guidance during coronary interventions, providing significant improvements in detecting arterial blockages.

Embolic Protection

- FilterWire EZ® Embolic Protection System: An innovative solution designed to capture dislodged material during interventional procedures, significantly decreasing the risk of complications such as heart attacks and strokes.

Peripheral Interventions

Boston Scientific actively addresses peripheral artery disease through:
- Balloon Catheters and Stents: Specifically designed for peripheral applications.
- PolarCath® System: Utilizing CryoPlasty® therapy, this system effectively treats blockages in peripheral arteries.
- NexStent® Carotid Stent System: Built to treat common carotid artery diseases with a flexible design to accommodate varying vascular anatomies.

Neurovascular Intervention

In addressing conditions of the neurovascular system, Boston Scientific provides:
- Coils and Stents: Such as GDC® coils for the treatment of brain aneurysms and the Wingspan® Stent System for intracranial atherosclerosis.
- Micro-Catheters and Embolic Devices: Designed for precise interventions in neurovascular scenarios.

Vascular Surgery

Boston Scientific focuses on grafts for both abdominal and thoracic aortic aneurysms to treat severe vascular disease conditions that necessitate surgical intervention.

Electrophysiology

Their electrophysiology solutions offer comprehensive capabilities to diagnose and treat arrhythmias:
- Radiofrequency (RF) Generators: Used in catheter-based ablation procedures.
- Cooled Ablation Catheters: Like the Chilli II®, engineered to enhance the efficacy of arrhythmia treatments.

Cardiac Rhythm Management

Following the acquisition of Guidant, Boston Scientifics cardiac rhythm management portfolio has grown substantially to include:
- Implantable Cardioverter Defibrillators (ICDs): Such as the VITALITY® series that deliver essential life-saving therapies.
- Cardiac Resynchronization Therapy (CRT) Devices: Aimed at heart failure patients, including devices in the CONTAK RENEWAL® series.
- Pacemakers: The INSIGNIA® series incorporates advanced sensors for personalized pacing according to patient-specific activity levels.

Endosurgery Segment

Boston Scientifics endosurgery division presents a diverse offering of products targeting various interventions:

Gastrointestinal Interventions

- Esophageal, Gastric, and Duodenal Tools: Including biopsy forceps and balloon catheters for diagnosing and managing gastrointestinal diseases.
- Colorectal Products: Targeting conditions like polyps and colorectal cancer with instruments for effective polypectomy and biopsy.

Pancreatico-Biliary Interventions

Innovative tools for addressing diseases affecting the liver and pancreas, including advanced catheter systems that enhance diagnostic and therapeutic capabilities.

Urological Interventions

Devices designed for prostate interventions to treat benign prostatic hyperplasia (BPH) and urinary incontinence, employing techniques for tissue resection and thermotherapy.

Oncology Solutions

Boston Scientific offers a range of technologies geared toward tumor treatment via methodologies like embolization and radiofrequency ablation.

Neuromodulation Segment

Boston Scientific has made significant strides in the neuromodulation area, developing solutions for:
- Cochlear Implants: Aiming to restore hearing among patients with profound hearing loss.
- Spinal Cord Stimulation Systems: For effective pain management solutions, providing relief for patients with chronic pain conditions.

Overall Impact

Boston Scientific’s vast portfolio of medical devices and solutions across cardiovascular health, endosurgical procedures, and neuromodulation propels forward advancements in patient care. The continuous innovation and introduction of new technologies underscore the companys commitment to addressing diverse medical needs, ultimately shaping the future landscape of healthcare delivery and patient outcomes. The ongoing refinement of existing products and the exploration of new therapeutic areas reflect Boston Scientifics proactive engagement with the evolving healthcare environment.